Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse

Andrew Kent, Marc Schwartz, Christine M. McMahon, Maria L. Amaya, Clayton A. Smith, Jennifer Tobin, Kelsey Marciano, Rebecca Rezac, Grace Bosma, Daniel A. Pollyea, Jonathan A. Gutman